NCT00044460View on ClinicalTrials.gov

Efficacy and Safety In Poorly Controlled Type 2 Diabetics

PHASE4CompletedINTERVENTIONAL

Enrollment

142

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

April 10, 2003

Study Completion Date

April 10, 2003

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

rosiglitazone

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY